Pacira Biosciences Inc (NASDAQ:PCRX)

57.42
Delayed Data
As of Jun 24
 +1.14 / +2.03%
Today’s Change
45.05
Today|||52-Week Range
82.16
-4.57%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Pacira Biosciences Inc have a median target of 83.00, with a high estimate of 94.00 and a low estimate of 54.00. The median estimate represents a +44.55% increase from the last price of 57.42.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Pacira Biosciences Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.86
Sales
$174.3M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.80%
 
 
 
 
 
 
Growthannually 13.09%
 
 
 
 
 
 

Sales

Growthquarterly 10.30%
 
 
 
 
 
 
Growthannually 30.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.